Trial Details

COMPLETED
Basic Information
Clinical ID c838
Identifier NCT01666535
Trial Title Infliximab IBD Influenza Vaccine Study
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease
Interventions BIOLOGICAL: Influenza vaccination
Participant Information
Sponsor University of Calgary
City Calgary
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2025-09-12
Primary Completion Date 2025-03-13
Completion Date 2025-08-13